Regeneus’ product pipeline consists of two platform technologies, Progenza™ and Sygenus, across three target therapeutic areas: osteoarthritis, neuropathic pain and skin wound healing.

Progenza™

Allogenic Adipose MSC plus MSC Secretions
Secretome with Bioactive Molecules & Exosomes

R&D
Preclinical
Phase 1
Phase 2
Phase 3
In-market
Osteoarthritis
Neuropathic Pain

Sygenus

Allogenic Adipose MSC Secretion
Secretome with Bioactive Molecules & Exosomes

R&D
Preclinical
Phase 1
Phase 2
Phase 3
In-market
Age Spots and Acne
Neuropathic Pain
Wound Healing
Vulva Lichen Planus